CYP27C1
Basic information
Region (hg38): 2:127183832-127220313
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP27C1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 36 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 3 | 1 |
Variants in CYP27C1
This is a list of pathogenic ClinVar variants found in the CYP27C1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-127187294-C-T | not specified | Uncertain significance (Nov 09, 2023) | ||
2-127187305-C-T | not specified | Likely benign (Feb 15, 2023) | ||
2-127187308-C-G | not specified | Uncertain significance (Jul 25, 2023) | ||
2-127187309-C-G | not specified | Uncertain significance (Oct 30, 2023) | ||
2-127187314-G-A | Benign (Mar 29, 2018) | |||
2-127187332-T-G | not specified | Uncertain significance (Feb 19, 2025) | ||
2-127187353-T-C | not specified | Uncertain significance (Jul 19, 2022) | ||
2-127193120-G-A | Likely benign (Jun 01, 2022) | |||
2-127193188-A-G | not specified | Uncertain significance (Jan 18, 2025) | ||
2-127193194-T-G | not specified | Uncertain significance (Feb 21, 2024) | ||
2-127193210-G-A | not specified | Uncertain significance (Aug 05, 2024) | ||
2-127193228-G-A | not specified | Uncertain significance (Sep 14, 2021) | ||
2-127193243-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
2-127193251-T-C | not specified | Uncertain significance (Sep 06, 2022) | ||
2-127193791-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
2-127193809-C-G | not specified | Uncertain significance (May 04, 2023) | ||
2-127193820-A-C | not specified | Uncertain significance (Dec 30, 2024) | ||
2-127193839-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
2-127193845-T-C | not specified | Uncertain significance (Feb 27, 2025) | ||
2-127195354-G-C | not specified | Uncertain significance (Feb 27, 2025) | ||
2-127195368-G-A | not specified | Uncertain significance (Dec 05, 2024) | ||
2-127195431-C-A | not specified | Uncertain significance (Mar 27, 2023) | ||
2-127195431-C-T | not specified | Likely benign (Nov 21, 2024) | ||
2-127195432-G-A | not specified | Uncertain significance (May 20, 2024) | ||
2-127195441-T-C | not specified | Uncertain significance (May 24, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP27C1 | protein_coding | protein_coding | ENST00000335247 | 7 | 35959 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.20e-7 | 0.775 | 125707 | 0 | 41 | 125748 | 0.000163 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.685 | 198 | 227 | 0.872 | 0.0000139 | 2417 |
Missense in Polyphen | 82 | 101.59 | 0.80717 | 1099 | ||
Synonymous | 0.427 | 87 | 92.2 | 0.943 | 0.00000571 | 754 |
Loss of Function | 1.31 | 12 | 18.0 | 0.667 | 9.49e-7 | 198 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000626 | 0.000626 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of all-trans retinol (also called vitamin A1, the precursor of 11-cis retinal) to 3,4- didehydroretinol (also called vitamin A2, the precursor of 11-cis 3,4-didehydroretinal). Also acts on all-trans retinal and all- trans retinoic acid. {ECO:0000269|PubMed:27059013}.;
- Pathway
- Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II
(Consensus)
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- loftool
- 0.607
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.22
Haploinsufficiency Scores
- pHI
- 0.117
- hipred
- N
- hipred_score
- 0.379
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.300
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- retinol metabolic process;retinoic acid metabolic process;retinal metabolic process;oxidation-reduction process
- Cellular component
- cellular_component;membrane;intracellular membrane-bounded organelle
- Molecular function
- retinoic acid binding;monooxygenase activity;11-cis retinal binding;all-trans retinal binding;iron ion binding;heme binding;all-trans retinol 3,4-desaturase activity;all-trans retinal 3,4-desaturase activity;all-trans retinoic acid 3,4-desaturase activity;11-cis-retinal 3,4-desaturase activity;all-trans-retinol binding